top of page
Search
    • Dec 11, 2014

Phase1 Dose Escalation Study to Investigate Safety, Tolerability, and Pharmacokinetics of ANAVEX2-73

CNS Summit 2014, Boca Raton, FL

Ole Voges, Ingo Weigmann, Norman Bitterlich, Christoph Schindler and Christopher Missling


View Poster

bottom of page